News
(2)April 2026
NSPR proposes increasing authorized shares and electing three new directors
# 📜 What This Document Is 📰 This document is a **Proxy Statement (DEF 14A)**. In simple terms, think of it as a comprehensive guide and formal invitation for the company's annual meeting of stockholders. The purpose is to inform shareholders about what matters will be voted on, who runs the compa
InspireMD Seeks to Increase Authorized Shares to 250 Million
# 🧾 What This Document Is This is a **PRELIMINARY PROXY STATEMENT** (Form PRE 14A) for InspireMD, Inc. Think of it as the official "meeting agenda" and instruction booklet sent to shareholders ahead of an important vote. Its purpose is to give shareholders the information they need to vote on com
Peers in Medical Devices
Abbott Laboratories
Stryker Corporation
Medtronic plc
Boston Scientific Corporation
Edwards Lifesciences Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
DexCom, Inc.
STERIS plc
Zimmer Biomet Holdings, Inc.